01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Li R, Waga S, Hannon GJ, Beach D, Stillman B (1994)
Differential effects by the p21 CDK inhibitor on PCNAdependent
DNA replication and repair. Nature 371, 534-537.
Li S and Huang L (1997) In vivo gene transfer via intravenous
administration of cationic lipid-protamine-DNA (LPD)
complexes. Gene Ther 4, 891-900.
Li Z, Shanmugam N, Katayose D, Huber B, Srivastava S, Cowan
K, Seth P (1997) Enzyme/prodrug gene therapy approach for
breast cancer using a recombinant adenovirus expressing
Escherichia coli cytosine deaminase. Cancer Gene Ther 4,
113-117.
Lidner V, Reidy MA (1991) Proliferation of smooth muscle cells
after vascular injury if inhibited by an antibody against basic
fibroblast growth factor. Proc Natl Acad Sci USA 88, 3739-
3743.
Lieber A, He CY, Kirillova I, Kay MA (1996) Recombinant
adenoviruses with large deletions generated by Cre-mediated
excision exhibit different biological properties compared
with first-generation vectors in vitro and in vivo. J Virol 70,
8944-8960.
Lieu FH, Hawley TS, Fong AZ, Hawley RG (1997)
Transmissibility of murine stem cell virus-based retroviral
vectors carrying both interleukin-12 cDNAs and a third gene:
implications for immune gene therapy. Cancer Gene Ther
4, 167-175.
Lin KF, Chao J, Chao L (1995) Human atrial natriuretic peptide
gene delivery reduces blood pressure in hypertensive rats.
Hypertension 26, 847-853.
Lin KF, Chao L, Chao J (1997) Prolonged reduction of high
blood pressure with human nitric oxide synthase gene
delivery. Hypertension 30, 307-313.
Linardopoulos S, Papadakis E, Delakas D, Theodosiou V,
Cranidis A, Spandidos DA (1993) Human lung and bladder
carcinoma tumors as compared to their adjacent normal
tissue have elevated AP-1 activity associated with the
retinoblastoma gene promoter. Anticancer Res 13, 257-262.
Linzer DP and Levine AJ (1979) Characterization of a 54k
dalton cellular SV40 tumor antigen present in SV40
transformed cells and uninfected embryonal carcinoma cells.
Cell 17, 43-52.
Liotta LA, Steeg PS, and Stetler-Stevenson WG (1991) Review.
Cancer metastasis and angiogenesis: An imbalance of
positive and negative regulation. Cell 64, 327-336.
Litzinger DC, Brown JM, Wala I, Kaufman SA, Van GY, Farrell
CL, Collins D (1996) Fate of cationic liposomes and their
complex with oligonucleotide in vivo. Biochim Biophys
Acta 1281, 139-149.
Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R,
MacDonald ME, Stuhlmann H, Koup RA, Landau NR
(1996) Homozygous defect in HIV-1 coreceptor accounts for
resistance of some multiply-exposed individuals to HIV-1
infection. Cell 86, 367-377.
Liu X, Miller CW, Koeffler PH, Berk AJ (1993) The p53
activation domain binds the TATA box-binding polypeptide
in holo-TFIID, and a neighboring p53 domain inhibits
transcription. Mol Cell Biol 13: 3291-3300.
Gene Therapy and Molecular Biology Vol 1, page 147
147
Liu Z-g, Hsu H, Goeddel DV, and Karin M (1996) Dissection of
TNF receptor 1 effector functions: JNK activation is not
linked to apoptosis while NF-kB activation prevents cell
death. Cell 87, 565-576.
Lowe S and Ruley HE (1993) Stabilization of the p53 tumor
suppressor is induced by adenovirus-5 E1A and accompanies
apoptosis. Genes Dev 7, 535-545.
Lowe SW, Jacks T, Housman DE, and Ruley EH (1994)
Abrogation of oncogene-associated apoptosis allows
transformation of p53-deficient cells. Proc Natl Acad Sci
USA 91, 2026-2030.
Lubovy M, McCune S, Dong JY, Prchal JF, Townes TM, Prchal
JT (1996) Stable transduction of recombinant adenoassociated
virus into hematopoietic stem cells from normal
and sickle cell patients. Biol Blood Marrow Transplant 2,
24-30.
Ludlow, J.W., Shon, J., Pipas, J.M., Livingston, D.M. and
DeCaprio, J.A. (1990) The retinoblastoma susceptibility gene
product undergoes cell cycle-dependent dephosphorylation
and binding to and release from SV40 large T. Cell 60, 387-
396.
Luhrs CA, Raskin CA, Durbin R, Wu B, Sadasivan E,
McAllister W and Rothenberg SP (1992) Transfection of a
glycosylated phosphatidylinositol-anchored folate-binding
protein complementary DNA provides cells with the ability
to survive in low folate medium. J Clin Invest 90, 840-847.
Luo F, Zhou SZ, Cooper S, Munshi NC, Boswell HS, Broxmeyer
HE, Srivastava A (1995) Adeno-associated virus 2-mediated
gene transfer and functional expression of the human
granulocyte-macrophage colony-stimulating factor. Exp
Hematol 23, 1261-1267.
Lynch C, Israel DI, Kaufman RJ, Miller AD (1993) Sequences in
the coding region of clotting FVIII act as dominant inhibitors
of RNA accumulation and protein production. Hum Gene
Ther 4, 259-272.
Lynch CM, Clowes MM, Osborne WRA, Clowes AW, Miller
AD (1992) Long-term expression of human adenosine
deaminase in vascular smooth muscle cells of rats: a model
for gene therapy. Proc Natl Acad Sci USA 89, 1138-1142.
Mack DJ, Vartikar J, Pipas JM, Laimins LA (1993) Specific
repression of TATA-mediated but not initiator-mediated
transcription by wild-type p53. Nature 363: 281-283.
Mackensen A, Lindemann A, Mertelsmann R (1997)
Immunostimulatory cytokines in somatic cells and gene
therapy of cancer. Cytokine Growth Factor Rev 8, 119-
128.
Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Penalver
M, Averette HE (1997) In vitro antigene therapy targeting
HPV-16 E6 and E7 in cervical carcinoma. Gynecol Oncol
64, 18-25.
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y,
Fei H, Kim S, Lallone R, Ranganathan S, et al (1995) Leptin
levels in human and rodent: measurement of plasma leptin
and ob RNA in obese and weight-reduced subjects. Nat Med
1, 1155-1161.
Maffei M, Stoffel M, Barone M, Moon B, Dammerman M,
Ravussin E, Bogardus C, Ludwig DS, Flier JS, Talley M, et